August 27, 2016 8:16 AM ET

Pharmaceuticals

Company Overview of Corium International, Inc.

Executive Profile

Phyllis I. Gardner M.D.

Director and Chairman of Technology & Product Development Committee, Corium International, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 10 different industries.

See Board Relationships
65$83,538

Background

Dr. Phyllis I. Gardner, M.D., serves as a Member of the Board of Directors at Health Hero Network, Inc., Cellworks Group, Inc., Elim Biopharmaceuticals, Inc., SHINE, Inc., and MyHealthPage.com. Dr. Gardner serves as Director of Robert Bosch Healthcare Systems, Inc. She has been an Independent Director at Revance Therapeutics, Inc. since December 2006. and Corium International, Inc., since 2007. She serves on the Board of Directors of several public and private companies. ...

Corporate Headquarters

235 Constitution Drive
Menlo Park, California 94025

United States

Phone: 650-298-8255
Fax: 650-298-8012

Board Members Memberships

Director
2006-Present
Independent Director, Member of Compensation Committee and Member of Science & Technology Committee
2007-Present
Director and Chairman of Technology & Product Development Committee

Education

BS
University of Illinois-Urbana-Champaign
MD
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$42,000
Total Calculated Compensation$83,538
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
$1.0M
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.3M
Hirotaka Nakatomi Chairman, Chief Executive Officer and Chairman of Crisis Management Committee
Hisamitsu Pharmaceutical Co., Inc.
$126.0M
Stephen J. Farr Ph.D.Co-Founder, Chief Executive Officer, President and Director
Zogenix, Inc.
$434.9K
Konstantinos Alataris Ph.D.Chief Executive Officer, President and Director
Zosano Pharma Corporation
$105.3K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Corium International, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.